Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by Mugen1996on Sep 21, 2009 11:13pm

276 Views

Post# 16326005

RE: RE: RE: RE: Rosconi at UBS GLOBAL CONF. Sept 2

Have a good feeling in the short term...Volume has been increasing since the last trading sessions! Once that anonym house is done selling...we might have hell of a ride! Over 3$ the margins are back in and long resistance breaks. Once there...easy 5$!

Only new partenerships or FDA approval will result of upgrade from analysts...IMO

Best of luck!

Bullboard Posts

The investment impact of the U.S. 25% tariff on Canadian imports